Relaxera and CBL Patras Announce Exclusive Agreement on Manufacturing and Sales of Synthetic Human Relaxin-2
BENSHEIM, Germany and PATRAS, Greece, December 16, 2020 / B3C newswire / --Relaxera Pharmazeutische Gesellschaft mbH & Co. KG and CBL Patras (Chemical and Biopharmaceutical Laboratories) announce the signing of an exclusive contract for human relaxin-2. This cooperation agreement designates CBL as the exclusive manufacturing partner for synthetic human relaxin-2 (GMP and non-GMP) and Relaxera as the exclusive sales executive partner for relaxin. Relaxera currently undertakes research to charact...
Thomas Bernd Dschietzig Marion Michaelis Kleomenis Barlos Th Co Head Of Medical Sciences Relaxera Pharmazeutische Gesellschaft
Source: b3cnewswire.com